Log in to save to my catalogue

Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic r...

Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic r...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_801831fc5573429cafe08a03092ae655

Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review

About this item

Full title

Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review

Publisher

England: BMJ Publishing Group Ltd, Royal College of Psychiatrists and British Psychological Society

Journal title

BMJ mental health, 2023-02, Vol.26 (1), p.e300654

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd, Royal College of Psychiatrists and British Psychological Society

More information

Scope and Contents

Contents

Correspondence to Dr Aran Tajika, Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health, Kyoto, Kyoto, Japan; aran.tajika28@gmail.com Background Blinding of randomised controlled trials (RCTs) is very important for the accurate assessment of drug efficacy. Baethge et al searched fo...

Alternative Titles

Full title

Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_801831fc5573429cafe08a03092ae655

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_801831fc5573429cafe08a03092ae655

Other Identifiers

ISSN

2755-9734

E-ISSN

2755-9734

DOI

10.1136/bmjment-2023-300654

How to access this item